Tirzepatide Products (Mounjaro, Zepbound) Tirzepatide functions through dual GLP-1 and GIP receptor activation with a half-life around five days
They were all large-scale trials involving 3,000 to 18,000 patients who were either at high risk of or having established ASCVD, with trial durations ranging from 15 to 60 months
Tesamorelin works upstream, at the hypothalamic-pituitary axis level
But for many patients, these medications have led to devastating complications including gastroparesis (stomach paralysis), severe gastrointestinal injury, gallbladder disease, and even pancreatic cancer
Mickute M, Henson J, Rowlands AV et al (2021) Device-measured physical activity and its association with physical function in adults with type 2 diabetes mellitus
Phase 3 TRIUMPH trial data on long-term discontinuation effects are still emerging as of 2026